CP-GEP identifies high-risk T1a melanoma patients beyond established adverse features
- Author(s)
- Yu, WY; Olofsson Bagge, R; Pazhava, A; Weitemeyer, MB; Hölmich, LR; Johansson, I; Utikal, J; Venna, S; Jackson, J; Amaral, T; van Akkooi, A; Kolodney, MS; McArthur, GA; Meves, A;
- Details
- Publication Year 2026-02,Volume 94,Issue #2,Page 661-663
- Journal Title
- Journal of the American Academy of Dermatology
- Publication Type
- Research article
- Publisher
- Elsevier
- Keywords
- Cp-gep; Merlin Assay; melanoma; metastasis; risk prediction; sentinel lymph node biopsy
- Department(s)
- Medical Oncology
- Publisher's Version
- https://doi.org/10.1016/j.jaad.2025.10.036
- Open Access at Publisher's Site
https://doi.org/10.1016/j.jaad.2025.10.036- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-11-25 12:06:39
Last Modified: 2026-02-03 03:57:06